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Abstract
Background: The interactions between luteal, vascular endothelial, immune cells and its products: steroids, peptide
hormones, prostaglandins (PGs), growth factors and cytokines play a pivotal role in the regulation of corpus luteum
(CL) function. Luteal endothelial cells undergo many dynamic morphological changes and their action is regulated
by cytokines. The aims are: (1) to establish in vitro model for bovine luteal endothelial cells examination; (2) to
study the effect of cytokines: tumor necrosis factor alpha (TNFalpha) and interferon gamma (IFNgamma) on cell
viability, leukotrienes (LTs) and PG synthases, and endothelin-1 (EDN-1) mRNA, protein expression and their
secretion in bovine immortalized luteal endothelial (EnCL-1) cells.
Methods: The primary cultures of bovine luteal endothelial cells were immortalized by transfection with vector
carrying the Simian virus 40 T-antigen (SV40 T-ag) sequence. Expression of SV40 T-ag gene in EnCL-1 cells was
confirmed by RT-PCR and immunofluorescence staining showed the presence of endothelial cell markers:
VE-cadherin and von Willebrand factor. EnCL-1 cells were stimulated by TNFalpha with IFNgamma (50 ng/ml each)
for 24 h. Cell viability, mRNA expression (real time RT-PCR), protein expression (western blotting) for LTC4 synthase
(LTC4S), LTA4 hydrolase (LTA4H), PGE2 and PGF2alpha synthases and endothelin-1 (EDN-1), and levels of LTs (B4
and C4) and PGs (E2 and F2alpha) and EDN-1 in the medium (EIA) were evaluated.
Results: We received immortalized luteal endothelial cell line (EnCL-1). Cytokines did not change EnCL-1 cell
viability but increased mRNA expression of LTC4S, LTA4H, PGE2 and PGF2alpha synthases and EDN-1. EDN-1/2/3,
LTC4 and PGF2alpha synthases protein expression were elevated in the presence of TNFalpha/IFNgamma, and
accompanied by increased EDN-1, LTC4 and PGF2alpha secretion. Cytokines had no effect on PGES and LTA4H
protein expression, and PGE2 and LTB4 release.
Conclusions: TNFalpha and IFNgamma modulate EnCL-1 cell function. Moreover, established EnCL-1 cell line
appears to be a good model for investigating the molecular mechanisms related to cytokines action and aa
metabolites production in cattle.
Background
Although corpus luteum (CL) is a transient gland, it is
one of the most vascularized tissues in the body [1], with
endothelial cells representing greater than fifty percent of
t h et o t a lc e l l s[ 2 , 3 ] .A n g i o g e n e s i si sc r i t i c a lt oC Ld e v e l -
opment, whereas endothelial cells decline occurs during
luteolysis [4]. On the other side, endothelial cells play a
crucial role in a complex processes of tumor neovascular-
ization [5], including CL cancers [6]. Because of these
important and multiplex functions of endothelial cells in
CL vascularity, the establishment of an experimental
model of immortalized endothelial cells from bovine CL
is a prerequisite for the study of cellular and molecular
mechanism in this tissue. So far, the majority of studies
have been conducted on fresh isolated or refrozen ali-
quots of bovine primary luteal endothelial cells [4,7-9] or
cell line received not directly from CL [10]. Immortalized
endothelial cells have been characterized in several kinds
of bovine tissues, such as the pulmonary and coronary
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is available [10]. There is a possibility that surface anti-
gens and/or genetic programming differs for endothelial
cells derived from various tissues, beside each kind of cell
is strictly species dependent [11]. Thus, the stable bovine
luteal endothelial cell line with determined fenotype and
genotype would be the convenient and useful model for
the future study.
Among mediators of interactions between different
types of CL cells, including endothelial cells, the univer-
sal factors are immune cells and their secreted products,
cytokines [12-14]. Endothelial cells are capable of tumor
necrosis factor a (TNFa) synthesis and secretion [15].
Depending on the immediate microenvironment, TNFa
may stimulate cell proliferation or induce apoptosis of
luteal endothelial cells [4]. TNFa a c t i o ni nt h eb o v i n e
CL is a dose dependent: a low concentration of TNFa
stimulates in vivo luteolytic factors, as well as induces
apoptosis; whereas the high concentration of TNFa sti-
mulates a survival pathway [16-19]. Moreover, TNFa
induced apoptosis in cultured bovine luteal endothelial
cells [20]. TNFa effect in the ovary was found to be
more effective when TNFa acted synergistically with
interferon g (IFNg; [13,19,21,22]). Reasonable is the gen-
eration of stable in vitro luteal endothelial cell culture
for investigating the complex signaling pathway and
transcriptional mechanisms regulated by cytokines in
physiological and pathophysiological conditions in
cattle.
The proper vascularization and endothelial cell activity
per se are essential for normal CL function [23]. The
effect of prostaglandins (PGs) on the vascularity of
bovine CL is well known [9,21,23-26]. The ovarian blood
flow has been shown to increase after PGE2 administra-
tion and decrease during spontaneous and PGF2a
induced luteolysis in cows [27]. An acute increase in the
luteal blood flow occurs as the first step of luteolysis in
response to PGF2a [3]. Both the density and the number
of blood vessels were higher in CLs obtained after PGF2a
administration than in those without PGF2a treatment
[21], which indicate that the number of blood vessels
with smooth muscle in the regressing CL increased as a
result of loosing steroidogenic cells and capillaries.
A mitogenic effect and increased proliferation were
observed after PGF2a treatment in bovine dispersed luteal
endothelial cells [23]. Moreover, PG receptors, as well as
leukotriene (LTs - other metabolites of arachidonic acid -
aa) receptors are present on endothelial cells [23,26],
which indicate that the endothelial cells of bovine CL are
target for PGs and LTs. Leukotrienes are commonly
known as the potential inflammatory factors that cause
edema in respiratory tract diseases, but they also play the
important role in reproduction and may enhance the
action of PGs [28]. We hypothesize that cytokines are
involved in aa metabolites action in bovine luteal
endothelial cells.
The main goal of this study was to determine the
effect of cytokines on aa metabolites action in bovine
immortalized luteal endothelial cells. We examined:
(i) the viability of EnCL-1 cells, (ii) mRNA expression
for LTA4 hydrolase (LTA4H), LTC4 synthase (LTC4S),
PGE2 and PGF2a synthases (PGES and PGFS) and
endothelin-1 (EDN-1), (iii) protein expression for
LTA4H, LTC4S, PGES, PGFS and EDN-1/2/3 and (iv)
accumulation of LTB4 and C4,P G E 2 and F2a and EDN-
1 in the culture medium after TNFa/IFNg stimulation.
Methods
Collection of CL for in vitro experiments
Healthy, normally cycling Holstein/Polish Black and
White (75/25%; respectively) cows (3-4 lactation) were
used for the collection of the ovaries with CL (in total 4
animals). The animals were eliminated by the owners
(Experimental Animal Farm of Polish Academy of
Sciences in Baranowo; Poland) from the dairy herds
because of their lower milk production. The estrus of the
cows was synchronized twice using an analogue of PGF2a
(dinoprost, Dinolytic; Upjohn - Pharmacia N.V.S.A.,
Belgium) injections with an 11-day interval as recom-
mended by a vendor. The onset of the estrus was deter-
mined by a veterinarian via per rectum USG examination
using a DRAMINSKI ANIMALprofi Scanner [29] and
confirmed by observing the signs of estrus (i.e. vaginal
mucus, standing behavior). The onset of estrus was deter-
mined as Day 0. Only cows with signs of estrus were
chosen for the study. Animals were slaughtered on Day
8-12 of the estrous cycle and the ovaries were obtained
within 20 min of the exsanguinations and transported on
ice to the laboratory.
Luteal endothelial cells isolation
Endothelial cells isolation was proceeded according to
the method described previously in details [8,26] using a
Dynabeads kit (140.03 Dynabeads
® M-450; Invitrogen,
Oregon, USA). Briefly, the Dynabeads were coated with
the specific antigen-lectin (BS-1; L 2380 Sigma; Chemi-
c a lC o . ,S tL o u i s ,M O ,U S A ) .T h eb e a d sc o a t e dw i t h
endothelial cells were attracted by a magnet to the well
of the tube and the supernatant was removed. After
washing with PBS, 1 ml of 0.1 M fucose (T 2252 Sigma)
solution was added to break the connection of endothe-
lial cells with beads. The free beads were then attracted
by a magnet to the well of the tube and the supernatant
with endothelial cells was collected. The obtained cell
suspension contained more than 85% of luteal endothe-
lial cells and only a few steroidogenic CL cells. The cells
were suspended in Dulbecco’s Modified Eagle’s medium
(DMEM/Ham’s F-12; 1: 1(v/v); D 2906 Sigma) in a 3 ml
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CO2/95% air atmosphere. After third passage the cells
were trypsinized and placed at the concentration of 2 ×
10
5 cells/ml into a 24-well culture plate. After 24-48 h
of culture cells reached confluence and were proceeded
the procedure of immortalization.
Experimental procedures
Experiment 1. Establishment of immortalized bovine
endothelial cell (EnCL-1) line and its phenotype char-
acterization The primary cultures of endothelial cells
were immortalized by transfection with the vector carry-
ing a Simian virus 40 T-antigen (SV40 T-ag) sequence.
Lipofectamine LTX (11514-015, Invitrogen) was used as
a transfection agent according to manufacturer’s instruc-
tion. The fast proliferating colonies were selected and
initially scanned for the presence of transfected vector -
SV40 T-ag. Expression of SV40 T-ag gene was further
confirmed by RT-PCR in selected passages of the cells
(13, 18, 23, 31, 40, 50
th). The selected immortalized cell
line call EnCL-1 was cultured for next 50 passages with-
out any sign of senescence. After 13
th passage every 5
th
passage of EnCL-1 cells were pulled and frozen in -80°C
in cryotube portions (1.5 ml at the concentration 2.0 ×
10
5/ml). Viability of unfrozen cells was higher than 85%
as assessed by trypan blue dye exclusion. Characteriza-
tion of EnCL-1 cell line was provided by fluorescence
morphology and cytoplasmatic protein - von Villen-
brand factor and cell to cell adhesion - VE-cadherin in
selected passages of EnCL-1 cells (13, 18, 23, 31, 40,
50
th).
Experiment 2. Effect of cytokines on production and
secretion of Arachidonic Acid metabolites in immor-
talized bovine endothelial cells (EnCL-1) The concen-
tration of TNFa and IFNg (each in the dose: 50 ng/ml),
and exposure time (24 h) were determined on the basis of
previous studies [18,19,22,26,30]. All treatments were con-
ducted in triplicates, four experiments were performed.
Experiment 2.1. Effect of TNFa and ifNg on the viabi-
lity of immortalized bovine luteal endothelial cells
(EnCL-1) The aim of the experiment was to evaluate
the percentage of live cells after stimulation with studied
cytokines comparing with non-treated cells. The EnCL-1
cells (13
th passage) were adjusted to 2.0 10
5/ml of med-
ium: DMEM supplemented with 5% calf serum (F 7524
Sigma) and 20 μg/ml gentamycin. Cells were cultured in
96-culture plates in a humidified incubator at 37.5°C in
5% CO2 and 95% air atmosphere. After 24 h, the cells
were washed with serum-free DMEM and the medium
was replaced by fresh medium: DMEM/Ham’sF - 1 2
supplemented with 0.1% (w/v) BSA and containing
20 μg/ml gentamycin. Then, the cells were treated
simultaneously with TNFa (recombinant human TNFa:
HF-13; Dainippon Pharmaceutical Co., Ltd., Osaka,
Japan) and IFNg (PBP007; AbD Serotec, Biokom,
Warsaw, Poland) for 24 h. Cell viability (TOX-1; Sigma)
was measured using commercially available colorimetric
assay kits according to the manufacturer"s instructions
as previously described [18].
Experiment 2.2. Effect of TNFa and ifNg on mRNA
and protein expression of LTC4 synthase, LTA4 hydro-
lase, PGE2 synthase, PGF2a synthase and endothelin-1
in bovine endothelial immortalized cells (EnCL-1)
The aim of the experiment was to examine whether
TNFa and IFNg affect mRNA and protein expression of
selected factors. Dispersed, unfrozen EnCL-1 cells (13
th
passage) were seeded at 2.0 × 10
5 viable cells in 1 ml of
cultured medium in 24-well culture plates (3524,
Costar). After 18 h of culture in DMEM medium con-
taining 5% CS, the medium was replaced with DMEM
containing 0.1% BSA with or without TNFa/IFNg.
mRNA expression was quantitavely measured by real-
time RT-PCR for LTC4S, LTA4H, PGES, PGFS and
EDN-1 and protein expression was measured by western
blotting for LTC4S, LTA4H, PGES, PGFS and EDN-1/2/
3 as previously described [26,30]. The sequences of used
primers are described in Table 1. The cells were dis-
rupted with TRIZOL Reagent (15596, Invitrogen) and
frozen at -80°C until processed for RNA isolation and
Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Separately, the cells were frozen at -80°C until
processed for protein isolation.
Experiment 2.3. Effect of TNFa and ifNg on prosta-
glandins, leukotrienes and endothelin-1 release by
EnCL-1 cells T h ea i mo ft h ee x p e r i m e n tw a st os t u d y
the effect of TNFa and IFNg on release of PGE2, PGF2a,
LTB4, LTC4 and EDN-1 by EnCL-1 cells.
After incubation, media from Experiment 2.2 were col-
lected into tubes containing 10 μl of stabilizer [0.3 M
EDTA and 1% aspirin, A 2093; Sigma] for each 500 μlo f
medium and stored at - 20°C until EIA determinations.
Total RNA isolation
Total RNA was extracted from EnCL-1 cells using TRI-
ZOL Reagent according to the manufacturer’si n s t r u c -
tions. One microgram of each sample of total RNA was
reverse transcribed using the SuperScript First-Strand
Synthesis System for RT-PCR (11904-018 Invitrogen), as
described in the supplier’s protocol.
Conventional PCR
mRNA expression of the SV40 T-ag was confirmed by
conventional PCR using primers for SV40 T-ag detailed
in Table 1. The EnCL-1 cells cDNA was amplified with
JumpStar™ REDTaq™ ReadyMix PCR Reaction Mix
(P 0982; Sigma). The PCR conditions were as follows:
3m i n ,9 5° Ca n d3 0s e c ,5 8 ° C ,a n d3 0s e c7 2 ° Cf o r
30 cycles. The samples were electrophoresed on 1,5%
agarose gel containing ethidium bromide.
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EnCL-1 were plated in 2- and 4- well chamber slides at
a concentration 1 × 10
5 cells/ml and after 24 h the cells
were fixed with 4% paraformaldehyde, washed 3x with
PBS and blocked with PAV/10% NDS (normal donkey
serum) 1 h. Then, the cells were incubated overnight
with primary antibodies specific to von Willenbrand fac-
tor and VE-cadherin. Next, the cells were washed 3x
with PBS and incubated 1 h room temp. with secondary
antibodies conjugated with cyanine 3 (CY
3;J a c k s o n
I m m u n o R e s e a r c h ,W e s tG r o v e ,P A ) .F u r t h e r m o r e ,t h e
cells were counterstained with DAPI UltraCruz™
Mounting Medium (sc-24941; Santa Cruz Biotechnol-
ogy). EnCL-1 cells were visualized with confocal imaging
using a Nicon C1 confocal microscope.
Real-time PCR quantification
Quantitative fluorescence real-time PCR was performed
using the Applied Biosystems 7300 System (850 Lincoln
Centre Drive Foster City, CA 94404 USA) with a SYBR
Green PCR master mix (4367659; Power SYBR
® Green
PCR Master Mix; Applied Biosystems) following the
manufacturer’s instructions. Real-time PCR (25 μl)
included 12.5 μl SYBR Green PCR Master Mix, 0.5 μM
sense and antisense primers each, and reverse-tran-
scribed cDNA (1 μl of cDNA). Primer sequences are
detailed in Table 1. For quantification, standard curves
consisting of serial dilutions of the appropriate purified
cDNA were plotted. Amplification was proceeded by an
initial denaturation step (15 min at 95°C). The PCR pro-
grams for each gene were performed as follows: 40
cycles of denaturation (15 sec at 95°C), annealing (30
sec at 56°C), and elongation (60 sec at 72°C). After PCR,
melting curves were acquired by stepwise increases at a
temperature of 50-95°C to ensure that a single product
was amplified in the reaction. The data obtained from
the real-time RT-PCR for LTC4S, LTA4H, PGES, PGFS
and EDN-1 were normalized against GAPDH. Control
reactions in the absence of reverse transcriptase were
performed to test for genomic DNA contamination. The
specify of the PCR products for examined genes was
confirmed by gel electrophoresis and sequencing. The
sequence homology obtained in the experiment was
99%. Dissociation curve analysis was performed after
each real-time experiment to confirm the presence of
only one product and the absence of the formation of
primer dimmers. The threshold cycle number (Ct) for
each tested gene X was used to quantify the relative
abundance of the gene; arbitrary units were calculated
as: 2
-{Δ}Ct =2
- (Ct target gene-Ct housekeeping gene).
EIA determination
Concentration of PGE2 in culture media was determined
by EIA as previously described [31]. The PGE2 standard
curve ranged from 0.07 to 20 ng/ml and the ID50 of the
a s s a yw a s1 . 2 5n g / m l .T h ei n t r a -a n di n t e r - a s s a yC V
averaged 6.9% and 9.7% respectively. Concentration of
PGF2a in culture media was determined by EIA as
described previously [31].
The PGF2a standard curve ranged from 0.07 to 20 ng/
ml, and the ID50 of the assay was 1.82 ng/ml. The intra-
and inter-assay CV were 7.4% and 11.6% respectively.
Concentration of EDN-1 in culture media was deter-
mined by EIA using commercially kit (385131, Endothe-
lin-1 EIA Kit, Cayman, Cayman Chemical, Ann Arbor,
MI, USA). The EDN-1 standard curve ranged from 0.39
to 250 pg/ml and the ID50 of the assay was 7.8 pg/ml.
The intra- and inter-assay CV was 10.0%.
The concentrations of LTB4 and C4 in culture media
were determined using commercially available EIA kits
(520211, Leukotriene C4 EIA Kit, 520111, Leukotriene B4
EIA Kit; Cayman) according to Korzekwa et al. [19]. The
LTB4 standard curve ranged from 1.96 to 1000 pg/ml,
and the effective dose for 50% inhibition (ID50) of the
Table 1 Oligonucleotide sequences used for RT-PCR
Gene Oligonucleotide sequences Product size (bp) GenBank/REFERENCES
GAPDH F5 ’-CACCCTCAAGATTGTCAGCA-3’
R5 ’-GGTCATAAGTCCCTCCACGA-3’
103 BC102589
LTA4H F5 ’-CCCTAAAGAACTGGTGGCACT-3’
R5 ’-GACTTTTCCACCTGCTCTTTC-3’
240 NM00103428
[46]
LTC4S F5 ’-CCTGCTGCAAGCCTACTTCT-3’
R5 ’-GTTCACTTGGGCTCGGTAGA-3’
137 NM001046098
PGES F5 ’-ATCGTGACGGTCCGTCTCTAA-3’
R5 ’-GCCCTTTGAGATTGTGACAGG-3’
158 NM174443
[47]
PGFS F5 ’-TGTGGTGCACGTATCACGACA-3’
R5 ’-AATCACGTTGCCGTCCTCATC-3’
169 S54973
[47]
EDN-1 F5 ’-CAAATGCATCCTGCCTGGTC-3’
R5 ’-ATTGCCACCCCCATAGAGGA-3’
178 X52740
[25]
SV40 T-ag F5 ’-GCAATCGAAGCAGTAGCAATC-3’
R5 ’-CAGCTAATGGACCTTCTAGG-3’
385 SV40gp6
[48]
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cients of variation were on average 4.1% and 6.2%,
respectively. The LTC4 standard curve ranged from 0.98
to 500 pg/ml and the effective dose for 50% inhibition
(ID50) of the assay was 1.85 pg/ml. The intra- and inter-
assay CV were on average 4.9% and 7.4%, respectively.
Western blot analysis
The equal amounts (30 μg) of protein were dissolved in
SDS gel-loading buffer (50 mM Tris-HCl, pH 6.8; 4%
SDS, 20% glycerol and 2% b-mercaptoethanol), heated
to 95°C for 4 min and separated on 10% (for GAPDH,
PGFS, LTA4H, EDN-1/2/3) and 15% (for LTC4S and
mPGES-1) SDS-PAGE. Separated proteins were electro-
blotted onto 0.2 μm nitrocellulose membrane in transfer
buffer (20 mM Tris-HCl buffer, pH 8.2; 150 mM gly-
cine, 20% methanol). After blocking in 5% non-fat dry
milk in TBS-T buffer (Tris-buffered saline, containing
0.1% Tween-20) for 1.5 h at 25.6°C, the membranes
were incubated overnight with 1:2000 anti-lung-type
PGFS antiserum antiserum [32], or 1:1000 polyclonal
anti-mPGES-1 antibodies (160140; Cayman) or 1:1000
polyclonal LTC4 synthase antibody (sc-20108; Santa
Cruz Biotechnology, Inc, Heidelberg, Germany) or
1:1000 LTA4 hydrolase antibody (ab23677; Abcam,
Cambridge, UK) or 1:200 EDN 1/2/3 (sc-98727; Santa
Cruz Biotechnology, ET-1/2/3 = EDN-1, EDN-2,
EDN-3) at 4°C. Protein expression of GAPDH (G 8795;
Sigma, glyceraldehyde-3-phosphate dehydrogenase) as a
reference was used. Subsequently, proteins were
detected by incubating the membrane with 1:20000 dilu-
tion of secondary polyclonal anti-rabbit or anti-goat
alkaline phosphatase-conjugated antibodies (A 3687;
A 3562 Sigma) for 1.5 hour at 25.6°C. Immune com-
plexes were visualized using standard alkaline phospha-
tase visualization procedure. Western blots were
quantitated using Kodak 1D program (Eastman Kodak,
Rochester, NY, USA).
Statistical analysis
The statistical significance of differences between the
control and treated groups were analyzed by one-way
ANOVA followed by t-student’s post-hoc test (ANOVA;
GraphPAD PRISM Version 5.00, San Diego, CA; USA),
if the initial ANOVA was significant (P < 0.05).
Results
Experiment 1. Establishment of immortalized bovine
endothelial cell (EnCL-1) line and its phenotype
characterization
Selected immortalized endothelial cell line (EnCL-1) was
cultured till 50 passages without any sign of senescence,
which allowed to receive clear immortalized line of cells
with homogenous morphology and genotype, although
from 10 passage the line of cells has no any percentage
of primary luteal endothelial cells. Phase contrast
microscopy revealed that immortalized EnCL-1 cells
grew as confluent monolayers with typical cobblestone
morphology of primary endothelial cells. These cells
(13
th passage) were homogenous, polygonal and had
characteristic ovoid nuclei (Figure 1a,b). Moreover,
immunofluorescence staining revealed the presence of
endothelial cell markers: von Willebrand factor (Figure
1C,E,F) and VE-cadherin (Figure 1H,I) in EnCL-1 cells.
All isolated colonies expressed transfected vector.
Expression of SV40 T-ag gene in the cells was con-
firmed by RT-PCR (Figure 2).
Experiment 2. Effect of cytokines on production and
content of Arachidonic Acid metabolites in immortalized
bovine luteal endothelial cells (EnCL-1)
Experiment 2.1. Effect of TNFa and ifNg on the viability of
immortalized bovine luteal endothelial cells (EnCL-1)
TNFa/IFNg did not influence the viability of EnCL-1
cells after 24 h of incubation comparing to non-treated
cells (P > 0.05; Figure 3).
Figure 1 Characterization of morphology and cytoplasmatic
protein - von Villenbrand factor and cell to cell adhesion - VE-
cadherin in EnCL-1 cells. Cells reveal cobblestone morphology and
tendency to form monolayer on Petri dish (A-B, mag. x10, x40).
Localization of cytoplasmatic protein - vWF (panel E, mag. x10, x40)
and expression of VE-cadherin (panel H, mag. x10, x40). Cells (13
th
passage) were stained with specific antibodies and detected by
secondary antibodies labeled with fluorescent dyes, and analyzed
by confocal microscopy. The DNA was counterstained with DAPI
(blue, panels D, G). Panels C, F and I merged pictures of two
fluorescent dyes. Panel C mag. x100.
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protein expression of LTC4 synthase, LTA4 hydrolase, PGE2
synthase, PGF2a synthase and endothelin-1 in bovine
endothelial immortalized cells (EnCL-1)
TNFa/IFNg treatment of EnCL-1 cells resulted in
increased mRNA expression of PGES, PGFS, LTA4H,
LTC4S and EDN-1 in comparison to untreated cells
(P < 0.05; Figure 4A).
PGES and LTA4H protein expression were not
affected by cytokine treatment (P > 0.05), whereas
PGFS, LTC4S and EDN-1/2/3 protein expression were
stimulated by cytokines (P < 0.05; Figure 4B). Represen-
tive immunoblots of studies factors are presented in
Figure 4C.
Experiment 2.3. Effect of TNFa and ifNg on prostaglandins,
leukotrienes and endothelin-1 release by EnCL-1 cells
Cytokine treatment did not change the levels of PGE2
and LTB4 in the medium (P > 0.05), whereas cytokines
stimulated PGF2a,L T C 4 and EDN-1 release by EnCL-1
cells (P < 0.05; Table 2).
Discussion
The presence of SV40 T-ag in EnCL-1 cells and
repeated passage without the apparent senescence con-
firmed the permanent status of the selected cell line.
VE-cadherin and von Willebrand factor - positive fea-
tures support the endothelial phenotype of the cell line.
T antigen present in SV40 virus blocks cell death by
apoptosis and it also interacts with a cytoplasmic pro-
tein that contains BH3 domain [33]. The viral genes
achieve immortalization by inactivating the tumor sup-
pressor genes (p53, Rb)t h a ti n d u c ear e p l i c a t i v es e n e s -
cent state in cells. SV40 T antigen also induces
telomerase activity in the infected cells [33]. So far, each
study was conducted on the primary luteal endothelial
cells or line of endothelial cells but not received from
the bovine CL, which could possess different surface
antigens and at least physiology [10]. We established the
line of endothelial cells from bovine CL. To our knowl-
edge, this is the first report showing the morphological
and physiological properties of immortalized endothelial
cells collected from bovine CL. According to Davis et al.
[4], there are five types of bovine luteal endothelial cells
differ the presence of cytokeratin, expression of surface
antigens and neuronal cell adhesion molecule, capable
for the contact between steroidogenic and endothelial
cells within CL. We did not determine the morphologi-
cal type and surface antigens of received line of
endothelial cells than further study are necessary.
Endothelial cells posses receptors for TNFa
[20,34,35] and IFNg [36]. Several papers confirmed
synergistic, antiproliferative and proapoptotic action of
TNFa and IFNg in the CL [4,10,19,21,22]. In this
study, TNFa and IFNg treatment of cells increased
each of studied mRNA expressions. In addition, PGF2a
secretion and its synthase protein expression were sti-
mulated. Similar effect received Acosta et al. [8],
TNFa elevated PGF2a content in fresh and unfrozen
cells till 10
th passage in primary luteal endothelial
cells. Whereas, in the study of Cavicchio et al. [10],
cytokines stimulation was unresponsive to PGF2a
secretion in the luteal endothelial cells (passage 2).
The role of cytokines in regression of CL and cytokine
effect on the main luteolytic factor-PGF2a was consid-
ered, as enhancing PGF2a action in the functional and
structural luteolysis [17,19,20,34]. We also received the
stimulation of mRNA expression for PGES without the
effect on its protein expression and the level of PGE2
after cytokines treatment. Such an effect may be the
consequence of changes in intracellular regulation of
EnCL-1 cells, especially in mitochondrial activity. PGE2
enhances cellular proliferation, promotes angiogenesis,
inhibits apoptosis and suppresses immune responses in
cancerogenesis [35]. EnCL-1 cells potentially are pro-
grammed genetically for proliferation, thus cytokines,
typically causing apoptosis, may not cause such an
effect in our study and simultaneously stimulate PGE2
mRNA expression as kind of the preparation for prolif-
erative functions.
385 bp 
pSV-40 T-ag                      EnCL-1 
Figure 2 Expression of SV40 T-ag mRNA in EnCL-1 cells by
RT-PCR. Left - SV40 Tag positive control, Right-EnCL-1 cells.
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Figure 3 Viability of non-treated and cytokine (TNFa/IFNg)
stimulated EnCL-1 cells. No statistical differences were observed
between groups of non-treated and cytokine treated cells (P >
0.05), as determined by one-way ANOVA followed by t-student’s
multiple comparison test.
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Page 6 of 9Furthermore, we considered the role of cytokines in
connection with another aa metabolites-LTs in EnCL-1
cells. mRNA expression, as well as protein expression
for LTCS and LTC4 release were stimulated by cyto-
kines in EnCL-1 cells. Cytokines also stimulated LTA4H
mRNA expression but did not change LTA4H protein
expression and LTB4 secretion in EnCL-1 cells. Recently
we showed that primary bovine luteal endothelial cells
show mRNA expression for LT receptors (for LTB4 and
C4) [26]. So far LTs role in CL function focus on steroi-
dogenic cells in vitro [30] or concerned with processes
in bovine reproductive tract in vivo [37,38]. LTB4 plays
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Figure 4 mRNA and protein expression for selected aa metabolites in non- and cytokine treated EnCL-1 cells.L T C 4 synthase, LTA4
hydrolase, PGE2 synthase, PGF2a synthase and EDN-1 (A) mRNA, (B) protein expression of non-treated and cytokine (TNFa/IFNg) stimulated EnCL-
1 cells and (C) representive immunoblots of studies factors: 1 lane: Positive Control-bovine lung tissue, 2 lane-Control, 3 lane-TNFa/IFNg. Arrows
indicate statistical differences in the respective mRNA quantitative expression between groups of non-treated and cytokine treated cells (P <
0.05), as determined by one-way ANOVA followed by t-student’s multiple comparison test.
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Page 7 of 9luteotropic role in bovine CL, stimulating PGE2 secre-
tion, whereas LTC4 stimulate PGF2a and thus acts as
luteolytic factor in vivo [38]. There is lack of knowledge
about LTs role in CL vascular processes like angiogen-
esis and angioregression. It is possible that cytokine
effect in the ovary is modulated by LTs. The immune
cells (macrophages, monocytes and leukocytes) infiltrate
the ovary and secrete cytokines in process of ovulation
[39]. Cytokines affect non-steroidogenic ovarian cells,
causing the release of ovulation mediators, such as
metabolites of aa: PGs and LTs [39]. Thus, cytokines are
involved in ovarian processes during the estrous cycle
such as differentiation of CL, ovulation, luteolysis and
cooperate with PGs and LTs [26,30,37-39]. Beside, both
PGs and LTs appear to act in parallel in the regulation
of cell proliferation and neoangiogenesis [40].
We selected EDN-1 as one of the main factors pro-
duced in endothelial cells and checked the effect of
cytokines action on edn-1 mRNA expression and EDN-
1 release in EnCL-1 cells. Our results confirmed the ear-
lier studies [8,20,41] because the cytokines stimulated
both mRNA and its production in EnCL-1 cells. Protein
expression of EDN-1/2/3 was also elevated in our study
as summary of the expression for EDN-1, EDN-2 and
EDN-3. EDN-1 mRNA and protein is expressed in luteal
endothelial cells during all the estrous cycle and EDN-1
inhibits P4 production in late luteal phase [42,43], EDN-
2, in the early CL [44], whereas EDN-3, on the contrary
to mentioned EDN-1 and EDN-2, does not affect luteal
steroidogenesis [45]. Our results indicate that cytokines
enhance EDN-1/2/3 action and indicate on multiple
characteristic functions of EnCL-1 cells.
Concluding, cytokines modulate EnCL-1 cells function
by up-regulation of PGES, PGFS, LTA4H, LTC4S and
mRNA expression. Protein expression was elevated by
cytokines for PGFS and LTCS and simultaneously the
level of appropriate active metabolites of these synthases
products (PGF2a and LTC4) were higher after cytokine
stimulation. Protein expression for PGES and LTA4H
was not changed and release of products of these syn-
tases-PGE2 and LTB4 w a sa l s os t a b l e .B e s i d e ,m R N A
expression, level of EDN-1 and protein expression for
EDN1/2/3 were upregulated by cytokines, which suggest
that EnCL-1 cells show multiple potency, both prolifer-
eative and proapoptotic. In this respect, EnCL-1 cells
may serve as an appropriate model for investigating the
paradigm of counteraction of the luteolytic and luteotro-
pic properties of bovine CL. The received line of
immortalized EnCL-1 cells possess stable genotype and
phenotype. However, an intricate molecular structure of
the cells with multiple intervenient factors/hormones
and actions deserve to be defined.
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